Ischemia: Clinical Trials

225 trials for Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

225 completed. 225 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4225Completed 225

Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia

Trials (filtered) newest first · largest first

All 225 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Intravenous atropine immediately before wire crossing during primary percutaneous coronary intervention, Intravenous normal saline as placebo immediately before wire crossing during primary percutaneous coronary intervention - Myocardial Infarction
Phase 4CompletedAin Shams University1582025-08-012026-03-10
The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats
standard normal diet, low dose Streptozotocin, Sitagliptin (Novartis, USA) - Diabetic, Myocardial Infarction
Phase 4CompletedAl-Azhar University502024-10-302025-08-14
Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction
Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia - Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI)
Phase 4CompletedYoga Yudhistira402024-09-212025-02-27
TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
Ticagrelor - STEMI - ST Elevation Myocardial Infarction, Stent Thrombosis
Phase 4CompletedNational Institute of Cardiovascular Diseases, Pakistan17272023-08-242024-10-31
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
Henagliflozin - Myocardial Infarction, Heart Failure
Phase 4CompletedQian geng2482023-07-012025-12-02
Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction
Dapagliflozin 10mg/Tab, control group - Myocardial Infarction, Diabete Type 2
Phase 4CompletedQingdao Central Hospital1432023-05-082026-01-05
Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting
De-escalated Dual Antiplatelet Therapy, Dual Antiplatelet Therapy - Coronary Artery Disease, Coronary Artery Bypass Grafting
Phase 4CompletedChina National Center for Cardiovascular Diseases23002023-02-142025-08-27
MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon
Mamba Sirolimus-Eluting PTCA Balloon, Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Phase 4CompletedFrisch Medical Device Private Limited3602023-01-112026-03-11
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
Unfractionated heparin - STEMI - ST Elevation Myocardial Infarction
Phase 4CompletedUniversity Medical Centre Ljubljana6002022-03-102025-05-01
Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking
Colchicine 0.5 mg Oral Tablet - Anterior MI, Colchicine
Phase 4CompletedAin Shams University1002022-02-012022-08-23
3D PET Myocardial Blood Flow and Rb82 Infusion Profiles
Slow Infusion of Rubidium-82 - Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease
Phase 4CompletedOchsner Health System982021-12-282023-01-18
Prolonged Clinical Follow-up of OPTIMA-5
Recombinant Staphylokinase, Normal Saline - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 4CompletedThe First Affiliated Hospital with Nanjing Medical University2102021-10-292024-09-25
Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
cangrelor perfusion during PCI, standard PCI - ST-elevation Myocardial Infarction
Phase 4CompletedUniversity Hospital, Caen1282021-06-082026-04-02
Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
Nicorandil, Placebo - ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention
Phase 4CompletedFudan University15002021-06-012025-03-11
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
Adrenaline, Adenosine - Acute Coronary Syndrome, No-Reflow Phenomenon
Phase 4CompletedNational Institute of Cardiovascular Diseases, Pakistan2012021-01-012021-05-21
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
Continuation of oral anticoagulants, Interruption of oral anticoagulants - Aortic Valve Disease, Aortic Valve Stenosis
Phase 4CompletedSt. Antonius Hospital8582020-11-252024-05-31
The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression
Trazodone, Placebo oral tablet - Sleep Apnea Syndromes, Cerebral Infarction
Phase 4CompletedChang Gung Memorial Hospital222019-02-012020-04-06
Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
Bivalirudin, Enoxaparin, Unfractionated heparin - STEMI - ST Elevation Myocardial Infarction
Phase 4CompletedBeijing Anzhen Hospital29892019-01-112023-05-03
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)
Simultaneous CRRT, Conventional-indication CRRT, Esmolol - Cardiogenic Shock
Phase 4CompletedBeijing Anzhen Hospital1312018-12-182024-04-24
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
Rivaroxaban - Cerebral Infarction, TIA
Phase 4CompletedGeneral Hospital of Shenyang Military Region4002018-11-202025-08-21

Showing 20 of 225. Sign in to see all of them.

Narrower conditions

Myocardial Infarction (124)  ·  ST Elevation Myocardial Infarction (50)  ·  Coronary Artery Disease (21)  ·  Non-ST Elevated Myocardial Infarction (20)  ·  Stroke (19)  ·  Acute Coronary Syndrome (18)  ·  Cerebral Infarction (17)  ·  Cardiovascular Diseases (15)  ·  Angina, Unstable (14)  ·  Shock, Cardiogenic (10)  ·  Thrombosis (10)  ·  Atherosclerosis (8)  ·  Chronic Limb-Threatening Ischemia (8)  ·  Coronary Disease (7)

Broader conditions

Pathologic Processes (225)  ·  Pathological Conditions, Signs and Symptoms (225)  ·  Vascular Diseases (210)  ·  Cardiovascular Diseases (201)  ·  Necrosis (200)  ·  Infarction (198)  ·  Heart Diseases (180)  ·  Myocardial Ischemia (178)  ·  Myocardial Infarction (57)  ·  Nervous System Diseases (36)  ·  Arterial Occlusive Diseases (35)  ·  Arteriosclerosis (35)  ·  Brain Diseases (35)  ·  Central Nervous System Diseases (35)

Interventions

Ticagrelor (28)  ·  Clopidogrel (25)  ·  Aspirin (17)  ·  Prasugrel Hydrochloride (13)  ·  Abciximab (10)  ·  Tirofiban (7)  ·  Atorvastatin (6)  ·  Cilostazol (6)  ·  Heparin (6)  ·  Simvastatin (5)  ·  Sodium Chloride (5)  ·  cangrelor (5)  ·  Percutaneous Coronary Intervention (4)  ·  Rosuvastatin Calcium (4)  ·  bivalirudin (4)

Sponsors

Deutsches Herzzentrum Muenchen (6)  ·  University of Florida (4)  ·  University of Leipzig (4)  ·  University of Patras (4)  ·  AstraZeneca (3)  ·  Beijing Anzhen Hospital (3)  ·  Brasilia Heart Study Group (3)  ·  Flanders Medical Research Program (3)  ·  Fudan University (3)  ·  Seoul National University Bundang Hospital (3)  ·  St. Antonius Hospital (3)  ·  Yonsei University (3)  ·  Ain Shams University (2)  ·  Asan Medical Center (2)  ·  Assistance Publique - Hôpitaux de Paris (2)

Countries

United States (26)  ·  Germany (24)  ·  Italy (22)  ·  Canada (20)  ·  China (20)  ·  Netherlands (18)  ·  South Korea (18)  ·  United Kingdom (15)  ·  Spain (12)  ·  Czechia (11)  ·  Poland (11)  ·  France (10)  ·  Brazil (9)  ·  Sweden (9)  ·  Greece (8)

Top investigators

Adnan Kastrati, MD (5)  ·  David Antoniucci, MD (4)  ·  Dimitrios Alexopoulos, MD (3)  ·  Holger Thiele, MD (3)  ·  Marc Bosiers, MD (3)  ·  Olivier F Bertrand, MD, PhD (3)  ·  Albert Schoemig, MD (2)  ·  Albert Schomig, MD (2)  ·  Andrei C Sposito, MD, PhD (2)  ·  Dominick J Angiolillo, MD, PhD (2)  ·  Giulio Guagliumi, MD (2)  ·  Junbo Ge, M.D. (2)  ·  Lisheng Liu, MD (2)  ·  Paul Armstrong, MD (2)

Results publications

PMID 17964349, PMID 19264239, PMID 28286967, PMID 28527771, PMID 33647946, PMID 35224730, PMID 36526898, PMID 10080465, PMID 10595951, PMID 11693742, PMID 11965271, PMID 15745837, PMID 15956631, PMID 16116055, PMID 1627164, PMID 16271642, PMID 16271643, PMID 16286167, PMID 16507801, PMID 17105848, PMID 17145253, PMID 17145988, PMID 17261652, PMID 17398308, PMID 17478142, PMID 17697815, PMID 17698822, PMID 17908705, PMID 18227366, PMID 18227478, PMID 18355656, PMID 18451347, PMID 18549843, PMID 18567918, PMID 18585494, PMID 18645057, PMID 18667204, PMID 18765162, PMID 18804738, PMID 18849604, PMID 18940887, PMID 19007597, PMID 19106084, PMID 19108880, PMID 19151048, PMID 19220726, PMID 19231326, PMID 19246588, PMID 19276198, PMID 19309733

NIH funding

2009 (1), 2015 (1), 2018 (1), R01HL067683 (1), R01HL128816 (1), U01HL130163 (1)